Principle 3.

3.       Clinical trials should be subject to an independent review by an IRB/IEC.

3.1           A trial should be conducted in compliance with the protocol that received prior IRB/IEC approval/favourable opinion.

3.2           Periodic review of the trial by the IRB/IEC should also be conducted in accordance with applicable regulatory requirements.